|
76 |
Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial |
Gerstein HC, Colhoun HM, Dagenais GR, Diaz R, Lakshmanan M, *Pais P*, *Xavier D*, Atisso CM, et al.. |
The Lancet |
2019 |
|
77 |
Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial. |
Kausik K Ray, Helen M Colhoun, Michael Szarek, Marie Baccara-Dinet, *Denis Xavier*, et al.. |
The Lancet Diabetes and Endocrinology |
2019 |
|
78 |
Dabigatran in patients with myocardial injury after non-cardiac surgery (MANAGE): an international, randomised, placebo-controlled trial |
Devereaux PJ, Duceppe E, Guyatt G, Tandon V, Rodseth R, Biccard BM, Xavier D, Szczeklik W, Meyhoff CS, et al; MANAGE Investigators |
Lancet |
2018 |
|
79 |
Measuring performance on the Healthcare Access and Quality Index for 195 countries and territories and selected subnational locations: a systematic analysis from the Global Burden of Disease Study 2016 |
Fullman N, Yearwood J, Abay SM, Abbafati C, Abd-Allah F, Abdela J, Xavier D, et al; GBD 2016 Healthcare Access and Quality Collaborators |
Lancet |
2018 |
|
80 |
First Stroke Reduced 44 Percent by Well Tolerated Medications. Stroke Outcomes From the Heart Outcomes Prevention Evaluation 3 Study |
Bosch J, Lonn E, Zhu J, Pais P, Xavier D, Dans A, Diaz R, Hart R, Yusuf S |
Stroke |
2018 |
|
81 |
The International Polycap Study-3 (TIPS-3): Design, baseline characteristics and challenges in conduct |
Joseph P, Pais P, Dans AL, Bosch J, Xavier D, Lopez-Jaramillo P, Yusoff K, Santoso A, Talukder S, Gamra H, Yeates K, Lopez PC, Tyrwhitt J, Gao P, Teo K, Yusuf S; TIPS-3 Investigators |
Am Heart J |
2018 |
|
82 |
Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events in the ODYSSEY OUTCOMES Trial |
Szarek M, White HD, Schwartz GG, Alings M, Bhatt DL, Bittner VA, Chiang CE, Diaz R, Edelberg JM, Goodman SG, Hanotin C, Harrington RA, Jukema JW, Kimura T, Kiss RG, Lecorps G, Mahaffey KW, Moryusef A, Pordy R, Roe MT, Tricoci P, Xavier D, Zeiher AM, Steg PG; ODYSSEY OUTCOMES Committees and Investigators. |
J Am Coll Cardiol |
2018 |
|
83 |
Treadmill stress tests should not be part of "routine health check package" |
Pais P |
Indian Heart Journal |
2018 |
|
84 |
Low quality cardiovascular care is important coronary risk factor in India |
Gupta R, Khedar RS, Gaur K, Xavier D |
Indian Heart Journal |
2018 |
|
85 |
Effect of intensive lifestyle modification & metformin on cardiovascular risk in prediabetes: A pilot randomized control trial |
Kulkarni S, Xavier D, George B, Umesh S, Fathima S, Bantwal G |
Indian J Med Res |
2018 |
|
86 |
The changing patterns of cardiovascular diseases and their risk factors in the states of India: the Global Burden of Disease Study 1990-2016 |
Prabhakaran D, Jeemon P, Sharma M, Roth GA, Johnson C, Harikrishnan S, Gupta R, Pandian JD, Naik N, Roy A, Dhaliwal RS, Xavier D, et al; India State-Level Disease Burden Initiative CVD Collaborators |
Lancet Glob Health |
2018 |
|
87 |
Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017 |
Roth GA, Abate D, Abate KH, Abay SM, Xavier D, et.al; GBD 2017 Causes of Death Collaborators |
Lancet |
2018 |
|
88 |
Community Health Worker Interventions in Type 2 Diabetes Mellitus Patients: Assessing the Feasibility and Effectiveness in Rural Central India |
Jain V, Joshi R, Idiculla J, Xavier D |
Journal of Cardiovascular Disease Research |
2018 |
|
89 |
Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017 |
Stanaway JD, Afshin A, Gakidou E, Lim SS, Xavier D, et.al; GBD 2017 Risk Factor Collaborators |
Lancet |
2018 |
|
90 |
The increasing burden of diabetes and variations among the states of India: the Global Burden of Disease Study 1990–2016
|
Nikhil Tandon, Ranjit M Anjana, Viswanathan Mohan, Tanvir Kaur, Ashkan Afshin, Kanyin Ong, Satinath Mukhopadhyay, Nihal Thomas, Eesh Bhatia, Anand Krishnan, Prashant Mathur, R S Dhaliwal, D K Shukla, Anil Bhansali, Dorairaj Prabhakaran, Paturi V Rao, Chittaranjan S Yajnik, *Denis Xavier*, et al..
|
The Lancet Global Health |
2018 |